Application
Smoke Inhalation and Health Studies.
Environmental and Health Effects of Chemical Pesticides.
Impacts on Environment and Health of Air Particulate Matter and Microorganisms.
Health Evaluation of Indoor Gases.
Research on Biosafety Evaluation of Nanomaterials.
Health Impacts of Industrial Chemicals.
Research on Chronic Obstructive Pulmonary Disease, Lung Cancer and Other Related Diseases.
Description
The system is a multi-channel in vitro cell exposure system for respirable substances based on ALI (Air-Liquid Interface) technique. 3 concentrations and 1 control group cell exposure tests can be conducted in single test with min. 3 parallel samples for each concentration. Multi-concentration cell exposure system has advantages of ensuring sample homology among each concentration, high test efficiency and low sample consumption.
Features
ALI- Air-Liquid Interface Exposure.
Exposure flow rate of a single channel is 5-20ml.
Up to 3 concentrations and 1 control group test.
Aerosol concentration online monitoring.
Flow control accuracy ±1%F.S..
Compatible with quartz crystal microbalance.
Compatible with 6-channel and 12-channel transwell chambers.
Water bath temp control accuracy ±0.3℃.
Optional clean bench / safety cabinet to provide clean exposure environment.
Standards
OECD Guidelines
① OECD TG 403 Acute Inhalation Toxicity (2009);
② OECD TG 436 Acute Inhalation Toxicity; Acute Toxic Class Method (2009);
③ OECD TG 412 28d Sub-acute inhalation (2018);
④ OECD TG 413 90d Sub-chronic inhalation (2018);
bio-equip.cn
Shanghai Hongrui Biotechnology Co., Ltd. is a science and technology-based enterprise engaged in the independent research and development of biological engineering instruments and equipment. The company has multiple R&D pipelines, covering the research and production of various types of bioreactors, material handling and separation purification equipment. The manufacture and sale of anaerobic bioreactors are the company's main business. Since its establishment, the company has consistently focused on talent cultivation and technological innovation. By the middle of 2024, the company has obtained more than 40 patent certificates and one international patent certificate.